about
Treatment of Intravenous Leiomyomatosis with Cardiac Extension following Incomplete ResectionA single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years.Uterine fibroids: current perspectivesIntraobserver variability in fibroid size measurements: estimated effects on assessing fibroid growth.Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.Use of Chinese medicine correlates negatively with the consumption of conventional medicine and medical cost in patients with uterine fibroids: a population-based retrospective cohort study in Taiwan.Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for TherapyThe effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up.Role of vitamin D in uterine fibroid biologyTreatment for Uterine Fibroids: Searching for Effective Drug Therapies.Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman.Uterine fibroids are characterized by an impaired antioxidant cellular system: potential role of hypoxia in the pathophysiology of uterine fibroids.Vitamin d and the risk of uterine fibroids.Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study.Role of Transforming Growth Factor β in Uterine Fibroid Biology.Alternative Oral Agents in Prophylaxis and Therapy of Uterine Fibroids-An Up-to-Date Review.Minimally invasive procedures in the management of uterine fibroids.Current medical treatment of uterine fibroids.
P2860
Q26771239-BFE9380F-8A78-482D-B169-E712BE2D075EQ30278620-F9536C19-BF5F-44FC-A8D2-C4EEEDC8138EQ30443242-40C2D8A6-E782-4AD8-9D9F-3EE7F33CCCD5Q33751004-0C50F3DE-1223-468E-A0C9-3EFBEDFEB8F4Q34437666-FBF2D557-CE90-4303-984C-4ABAAF4B0CDEQ35552272-979443F3-2707-434D-BFCA-89923CC8790DQ35855640-195BC8B5-7A22-4EDB-8697-75ACDD1F0D4AQ35903532-99B805D6-42F8-41D4-8220-504BF2F5E01FQ36030956-EDE2945E-F76F-4009-A51F-B216979B9B1FQ36476226-1C2433AF-D011-4359-8A39-3DC878FB60ACQ36984302-6EEFBD20-CE58-492E-A1FE-EF3FB3BB28FFQ37049948-A809632F-D1CE-42F7-A6B2-30178AE8537DQ37671721-2C1A0676-5B41-4326-BCDF-360CBCDB9535Q39637393-4755031D-6A44-4EAF-8A55-4627B99A4B14Q47096314-30403A11-796E-4227-8E99-205BD6FB6D7BQ47217486-299ECE6A-7033-46B8-99CF-DD6980ECE7B3Q50285660-8F3F036A-7F4E-46FC-94A1-515038A9873DQ51736809-BD80E6F1-2AD4-4BC7-AB99-5066DF5815C1
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Innovative oral treatments of uterine leiomyoma
@ast
Innovative oral treatments of uterine leiomyoma
@en
type
label
Innovative oral treatments of uterine leiomyoma
@ast
Innovative oral treatments of uterine leiomyoma
@en
prefLabel
Innovative oral treatments of uterine leiomyoma
@ast
Innovative oral treatments of uterine leiomyoma
@en
P2860
P356
P1476
Innovative oral treatments of uterine leiomyoma
@en
P2093
Ayman Al-Hendy
Mohamed Sabry
P2860
P304
P356
10.1155/2012/943635
P577
2012-02-16T00:00:00Z